Tags

Type your tag names separated by a space and hit enter

Oncology Clinical Trials During the COVID-19 Pandemic.
Oncology (Williston Park). 2020 07 15; 34(7):265-269.O

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has rapidly spread all over the world in the past several months. No effective treatment for COVID-19 has been established. High transmissibility and considerable mortality rates have forced many national governments to implement quarantine measures. Many patients with cancer rely on clinical trials to receive their oncologic care, but the routine conduct of clinical trials has substantially changed because of the COVID-19 pandemic. The oncology research community should implement formal policies based on the guidance given from regulatory agencies, with the goal of minimizing the risks of COVID-19 infection while maintaining appropriate oncologic treatments for patients during this pandemic.

Authors+Show Affiliations

Oncology Center, Hospital Sírio-Libanês, Rua Dona Adma Jafet, 91, São Paulo, Brazil.Oncology Center, Hospital Sírio-Libanês, Rua Dona Adma Jafet, 91, São Paulo, Brazil. Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.Oncology Center, Hospital Sírio-Libanês, Rua Dona Adma Jafet, 91, São Paulo, Brazil. Instituto do Câncer do Estado de São Paulo, Avenida Doutor Arnaldo, São Paulo, Brazil; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32674214

Citation

Lara Gongoria, Aline Bobato, et al. "Oncology Clinical Trials During the COVID-19 Pandemic." Oncology (Williston Park, N.Y.), vol. 34, no. 7, 2020, pp. 265-269.
Lara Gongoria AB, Fontes Jardim DL, Bastos DA. Oncology Clinical Trials During the COVID-19 Pandemic. Oncology (Williston Park). 2020;34(7):265-269.
Lara Gongoria, A. B., Fontes Jardim, D. L., & Bastos, D. A. (2020). Oncology Clinical Trials During the COVID-19 Pandemic. Oncology (Williston Park, N.Y.), 34(7), 265-269.
Lara Gongoria AB, Fontes Jardim DL, Bastos DA. Oncology Clinical Trials During the COVID-19 Pandemic. Oncology (Williston Park). 2020 07 15;34(7):265-269. PubMed PMID: 32674214.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Oncology Clinical Trials During the COVID-19 Pandemic. AU - Lara Gongoria,Aline Bobato, AU - Fontes Jardim,Denis Leonardo, AU - Bastos,Diogo Assed, PY - 2020/7/17/entrez PY - 2020/7/17/pubmed PY - 2020/8/1/medline SP - 265 EP - 269 JF - Oncology (Williston Park, N.Y.) JO - Oncology (Williston Park) VL - 34 IS - 7 N2 - The coronavirus disease 2019 (COVID-19) pandemic has rapidly spread all over the world in the past several months. No effective treatment for COVID-19 has been established. High transmissibility and considerable mortality rates have forced many national governments to implement quarantine measures. Many patients with cancer rely on clinical trials to receive their oncologic care, but the routine conduct of clinical trials has substantially changed because of the COVID-19 pandemic. The oncology research community should implement formal policies based on the guidance given from regulatory agencies, with the goal of minimizing the risks of COVID-19 infection while maintaining appropriate oncologic treatments for patients during this pandemic. SN - 0890-9091 UR - https://www.unboundmedicine.com/medline/citation/32674214/Oncology_Clinical_Trials_During_the_COVID_19_Pandemic_ L2 - https://medlineplus.gov/infectioncontrol.html DB - PRIME DP - Unbound Medicine ER -